C. Bannan

发表

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection

J. Dowds, J. Dunne, I. Martín-Loeches, 2020, medRxiv.

Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection

J. Dowds, R. Kenny, P. McCluskey, 2021, Nutrients.

Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination

A. Folgori, E. Barnes, T. Hanke, 2021, NPJ vaccines.

HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction

P. Borrow, N. Stevenson, C. O’Farrelly, 2018, EBioMedicine.

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

T. Renné, I. Martín-Loeches, D. McGonagle, 2021, Journal of Thrombosis and Haemostasis.

Control of HIV infection by IFN-α: implications for latency and a cure

Á. McKnight, N. Stevenson, C. Bergin, 2017, Cellular and Molecular Life Sciences.

Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction

J. Dunne, R. Kiersey, I. Martín-Loeches, 2022, Journal of Thrombosis and Haemostasis.

1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study

J. Dowds, I. Martín-Loeches, B. Kent, 2022, Respiratory Research.

Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin

C. Merry, E. Relihan, C. Bergin, 2020, British journal of clinical pharmacology.

Point-of-care testing for HIV in an Irish prison setting: results from three major Irish prisons

G. Betts-Symonds, S. O’Dea, C. Bannan, 2016, International journal of STD & AIDS.

NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient.

K. Sevastianova, C. Bergin, J. Dean, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response

S. Norris, C. Bergin, S. McKiernan, 2017, PloS one.

Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection

C. Bergin, G. Hughes, R. O'Connor, 2020, JAC-antimicrobial resistance.

Reply: The Impact of Acute Illness Severity on Post–COVID-19 Sequelae Remains an Unsettled Question

J. Dowds, I. Martín-Loeches, L. Townsend, 2021, Annals of the American Thoracic Society.

Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study

R. Harding, C. Bergin, L. Avery, 2022, BMJ Global Health.

Acinetobacter spp. in Gunshot Injuries

J. Elston, C. Boutlis, C. Bannan, 2008, Emerging infectious diseases.

Delayed haemolysis after IV artesunate therapy for P. falciparum infection

C. Merry, Ròisìn O'Connor, C. Bergin, 2022, Travel Medicine and Infectious Disease.

Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response

I. Martín-Loeches, C. Bergin, N. Conlon, 2021, Journal of Thrombosis and Haemostasis.

Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression

J. Dunne, R. Kiersey, D. Byrne, 2021, Heliyon.

Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health

J. Dowds, P. Fallon, J. Dunne, 2020, Frontiers in Immunology.

Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination

A. Folgori, E. Barnes, T. Hanke, 2021, npj Vaccines.

Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID – protocol for a mixed-methods study

K. O’Brien, L. Avery, A. Cheung, 2022, BMJ Open.

Obesity Reduces mTORC1 Activity in Mucosal-Associated Invariant T Cells, Driving Defective Metabolic and Functional Responses

David K. Finlay, Linda V. Sinclair, G. Besra, 2019, The Journal of Immunology.

Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity

J. Dowds, J. Dunne, I. Martín-Loeches, 2021, Annals of the American Thoracic Society.

Relapsed Mantle Cell Lymphoma, Allogenic Stem Cell Transplantation and COVID-19

B. Crowley, C. L. Bacon, E. Vandenberghe, 2021 .

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

A. Folgori, A. Nicosia, Leo Swadling, 2019, Front. Immunol..

More on Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity.

J. Dowds, I. Martín-Loeches, L. Townsend, 2021, Annals of the American Thoracic Society.

Fatigue following COVID-19 infection is not associated with autonomic dysfunction

R. Kenny, C. Finucane, C. Bergin, 2021, PloS one.

Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report

A. Szűcs, C. Merry, C. Kerr, 2022, IDCases.

Study protocol for the St James's Hospital, Tallaght University Hospital, Trinity College Dublin Allied Researchers' (STTAR) Bioresource for COVID-19

R. McManus, R. Romero-Ortuño, P. Fallon, 2022, HRB open research.

A Unique Case of Concurrent Long Bone Osteomyelitis and Empyema Caused by Fusobacterium nucleatum.

S. Clarke, C. Merry, C. Bannan, 2018, Irish medical journal.

Control of HIV infection by IFN-α: implications for latency and a cure

Á. McKnight, N. Stevenson, C. Bergin, 2017, Cellular and Molecular Life Sciences.